Novome Announces Phase 1 Trial of GEMM Cell Therapy
July 03, 2021
Novome Biotechnologies has announced the beginning of its phase 1 trial evaluating NOV-001, a once-daily Genetically Engineered Microbial Medicine for the treatment of enteric hyperoxaluria.
“With this significant milestone, we are advancing toward our goal of becoming a leader in the field of living therapeutics,” Blake Wise, CEO of Novome said in a press release. “We believe that our Genetically Engineered Microbial Medicine (GEMM) cell therapies hold tremendous potential for patients across a wide range of diseases, including ulcerative colitis and irritable bowel syndrome, in addition to enteric hyperoxaluria.”
In the phase 1 clinical trial, researchers will first evaluate the safety, tolerability and strain colonization pharmacodynamic of NOV-001 in healthy volunteers followed by a prospective, randomized, placebo-controlled phase 2 trial comprising patients with enteric hyperoxaluria. Trial results are anticipated later in 2021.
“This is the first time a human will be dosed with therapeutically engineered bacteria designed to colonize and grow in the gut,” Wise told Healio. “With this study we hope to prove Novome's platform GEMM technology is safe and can drive predictable results in colonizing a human microbiota.”
About
The Alliance of Chief Executives is an active community of business leaders that focuses on deep strategic exchanges, challenging existing assumptions and generating fresh ideas.
Contact Us
Alliance of Chief Executives, LLC
2175 N. California Blvd.,
Suite 605
Walnut Creek, CA 94596
- 925-942-2400 Office
- 925-956-4424 Fax
- Email: info@allianceofCEOs.com
Newsletter
Subscribe to our newsletter and stay up to date with the latest Alliance news!
About
The Alliance of Chief Executives is an active community of business leaders that focuses on deep strategic exchanges, challenging existing assumptions and generating fresh ideas.
Newsletter
Subscribe to our newsletter and stay up to date with the latest Alliance news!
Recent Member News
Member Resources
Contact Us
2175 N. California Blvd., Suite 605
Walnut Creek, CA 94596
925-942-2400 Office
925-956-4424 Fax
Email: info@allianceofCEOs.com
2026 © Alliance of Chief Executives, LLC
